• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Extemporaneous compounding: a return to regulatory limbo?

作者信息

Winckler Susan C

机构信息

American Pharmaceutical Association, Washington, DC 20037, USA.

出版信息

J Pain Palliat Care Pharmacother. 2002;16(4):71-8. doi: 10.1080/j354v16n04_08.

DOI:10.1080/j354v16n04_08
PMID:14635828
Abstract

Extemporaneous compounding of medications has been an integral component of the practice of pharmacy and medicine since the practices began. A staple of early medical and pharmacy practice, even today many patients benefit from compounding at some point in their care. Unfortunately, the regulation of the practice has not been so consistent. With a recent decision by the US Supreme Court, compounding regulation is again uncertain. This commentary reviews compounding practice, the history of compounding regulation, and discusses the current regulatory status of the practice.

摘要

相似文献

1
Extemporaneous compounding: a return to regulatory limbo?
J Pain Palliat Care Pharmacother. 2002;16(4):71-8. doi: 10.1080/j354v16n04_08.
2
Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.与核药房配制指南制定相关的解释及未解决问题。
J Am Pharm Assoc (Wash). 2002 Sep-Oct;42(5):789-98. doi: 10.1331/108658002764653568.
3
FDA states policy on pharmacy compounding. Agency follows up on supreme court ruling.美国食品药品监督管理局(FDA)阐述了关于药房配制的政策。该机构对最高法院的裁决采取后续行动。
Am J Health Syst Pharm. 2002 Jul 1;59(13):1222, 1224. doi: 10.1093/ajhp/59.13.1222.
4
Pharmacist compounding vs veterinarian compounding: similarities and differences.
J Am Vet Med Assoc. 1994 Jul 15;205(2):256-60.
5
States boards of pharmacy compounding guidelines.各州药房配制指南。
J Am Vet Med Assoc. 1994 Jul 15;205(2):254-5.
6
Compounding botanicals: a legal perspective.复方植物药:法律视角
J Am Pharm Assoc (Wash). 1999 Jul-Aug;39(4):537-44. doi: 10.1016/s1086-5802(16)30475-2.
7
FDA, states discuss pharmacy compounding regulatory framework.
Am J Health Syst Pharm. 2013 Feb 1;70(3):180, 182. doi: 10.2146/news130010.
8
Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view.食品药品监督管理局现行良好生产规范法规在药学实践中的应用:法律视角
Contemp Pharm Pract. 1979 Fall;2(4):202-5.
9
Mixing it up: compounding pharmacy creates individualized medications.混合调配:复方药房配制个性化药物。
Holist Nurs Pract. 2004 Mar-Apr;18(2):108. doi: 10.1097/00004650-200403000-00009.
10
Extemporaneous compounding. The end of the road?临时调配。路的尽头?
Dermatol Clin. 1998 Apr;16(2):321-7. doi: 10.1016/s0733-8635(05)70014-0.

引用本文的文献

1
A Critical Assessment of Extemporaneous Formulations for Proton Pump Inhibitors: The Importance of Proper Vehicle Selection.质子泵抑制剂临时制剂的批判性评估:正确选择溶媒的重要性。
J Pediatr Pharmacol Ther. 2022;27(7):618-624. doi: 10.5863/1551-6776-27.7.618. Epub 2022 Sep 26.
2
Prescribing Pattern of Dermatological Compounding in Ethiopia: The Case of ALERT Hospital.埃塞俄比亚皮肤科复方制剂的处方模式:以阿莱尔特医院为例。
Integr Pharm Res Pract. 2022 Jan 6;11:1-8. doi: 10.2147/IPRP.S346395. eCollection 2022.
3
Extemporaneous Compounding Practice for Dermatologic Preparations in Ethiopian Public Hospitals: Regulatory Requirements and Quality Concerns.
埃塞俄比亚公立医院皮肤科制剂的临时调配实践:监管要求与质量问题
Risk Manag Healthc Policy. 2021 May 12;14:1933-1938. doi: 10.2147/RMHP.S300906. eCollection 2021.